COVID-19 : Pfizer-BioNTech’s vaccine found 90% effective in phase 3 trial
New Delhi: An experimental vaccine jointly developed by Pfizer and BioNTech was found to be 90 per cent effective in
Read MoreViral and Trending News
New Delhi: An experimental vaccine jointly developed by Pfizer and BioNTech was found to be 90 per cent effective in
Read More